Literature DB >> 34750583

The RNA helicase Ddx21 controls Vegfc-driven developmental lymphangiogenesis by balancing endothelial cell ribosome biogenesis and p53 function.

Katarzyna Koltowska1,2, Kazuhide S Okuda3,4,5, Marleen Gloger6, Maria Rondon-Galeano3,4,5, Elizabeth Mason4,5, Jiachen Xuan4,5, Stefanie Dudczig4,5, Huijun Chen3, Hannah Arnold6, Renae Skoczylas6, Neil I Bower3, Scott Paterson3,4,5, Anne Karine Lagendijk3, Gregory J Baillie3, Ignaty Leshchiner7,8, Cas Simons3,9, Kelly A Smith3,10, Wolfram Goessling7, Joan K Heath11,12, Richard B Pearson4,5,13,14, Elaine Sanij4,5,15,16, Stefan Schulte-Merker17,18, Benjamin M Hogan19,20,21,22,23.   

Abstract

The development of a functional vasculature requires the coordinated control of cell fate, lineage differentiation and network growth. Cellular proliferation is spatiotemporally regulated in developing vessels, but how this is orchestrated in different lineages is unknown. Here, using a zebrafish genetic screen for lymphatic-deficient mutants, we uncover a mutant for the RNA helicase Ddx21. Ddx21 cell-autonomously regulates lymphatic vessel development. An established regulator of ribosomal RNA synthesis and ribosome biogenesis, Ddx21 is enriched in sprouting venous endothelial cells in response to Vegfc-Flt4 signalling. Ddx21 function is essential for Vegfc-Flt4-driven endothelial cell proliferation. In the absence of Ddx21, endothelial cells show reduced ribosome biogenesis, p53 and p21 upregulation and cell cycle arrest that blocks lymphangiogenesis. Thus, Ddx21 coordinates the lymphatic endothelial cell response to Vegfc-Flt4 signalling by balancing ribosome biogenesis and p53 function. This mechanism may be targetable in diseases of excessive lymphangiogenesis such as cancer metastasis or lymphatic malformation.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34750583     DOI: 10.1038/s41556-021-00784-w

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  35 in total

1.  Fluoride research laboratory at the Copenhagen Dental school with the help of the scientific research council.

Authors: 
Journal:  Tandlaegebladet       Date:  1974-04

2.  [Differentiation of two cathepsins from cod muscle].

Authors:  K Musch; G Siebert; J V Davies; M Ebert
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1971-06

3.  [Exercise-induced asthma and inhaled steroids].

Authors:  F Morell
Journal:  Arch Bronconeumol       Date:  1994 Jun-Jul       Impact factor: 4.872

4.  Benign ureteral tumors: report of a case and review of the literature.

Authors:  M J Macksood; J B Smith
Journal:  J Am Osteopath Assoc       Date:  1984-10

5.  An unusual angiographic appearance of ergot poisoning.

Authors:  S G Doig; G Fell; J French
Journal:  Australas Radiol       Date:  1985-08

6.  Genetic counseling--still mostly genetics.

Authors:  W A Check
Journal:  JAMA       Date:  1980-07-25       Impact factor: 56.272

7.  [Gastric cancer treated by hematoporphyrin derivative(HPD)-laser--histopathological study of 10 gastrectomy specimens].

Authors:  Q F Zhu; Y C Huang
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  1986-11

8.  Release of 3H-dopamine and analogous monoamines from rat striatal tissue.

Authors:  R J Baldessarini; M Vogt
Journal:  Cell Mol Neurobiol       Date:  1988-06       Impact factor: 5.046

9.  Bell's palsy in children.

Authors:  P P Devriese
Journal:  Acta Otorhinolaryngol Belg       Date:  1984

10.  Metabolism of triacetin-derived acetate in dogs.

Authors:  B Bleiberg; T R Beers; M Persson; J M Miles
Journal:  Am J Clin Nutr       Date:  1993-12       Impact factor: 7.045

View more
  2 in total

Review 1.  The homeostatic regulation of ribosome biogenesis.

Authors:  Chunyang Ni; Michael Buszczak
Journal:  Semin Cell Dev Biol       Date:  2022-04-16       Impact factor: 7.499

2.  Identification of leucine-rich repeat-containing protein 59 (LRRC59) located in the endoplasmic reticulum as a novel prognostic factor for urothelial carcinoma.

Authors:  Lu Pei; Qingfeng Zhu; Xiaoping Zhuang; Honglian Ruan; Zhiguang Zhao; Haide Qin; Qiongqiong Lin
Journal:  Transl Oncol       Date:  2022-07-08       Impact factor: 4.803

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.